‘Research Luxembourg’, the initiative of the main players of Luxembourg public research, has launched its website.

Prof Dirk Brenner (DB) is Deputy Head of Research & Strategy and leads the Experimental and Molecular Immunology research group at the LIH Department of Infection and Immunity.

COVID-19 taskforce: Launch of national platform, FNR Call in the making

Dr Guy Berchem (GB) is an oncologist and Director of Research at the Centre Hospitalier de Luxembourg (CHL), having also recently been appointed Associated Medical Director at LIH. As a “clinician scientist” with dual expertise in both research and healthcare, Dr Berchem is currently playing a crucial role in the setup of clinical studies on Covid-19 in Luxembourg, in close collaboration with the Clinical and Epidemiological Investigation Centre (CIEC) at LIH.

The Communication team at the Luxembourg Institute of Health is pleased to announce the launch of #LIHtellmewhy, an innovative initiative of catchy cartoons aiming to explain the COVID-19 situation to young children aged four to eight.

Since the first outbreak of the novel pneumonia (COVID-19) in Wuhan (China), a lot of conjectures have been formulated as to the origin of the causative virus, SARS-CoV-2, which is the seventh coronavirus known to infect humans.

Research Luxembourg, a joint initiative of the main players in Luxembourg's public research sector, is mobilising its knowledge and its human and material resources to help address the challenge of COVID-19.

The Immune-Endocrine-Epigenetics Research Group in the Department of Infection and Immunity investigates how epigenetic processes such as DNA methylation integrate the environment and inherited traits to predispose individuals to diseases. In the context of the FNR funded CORE grant “Age Acceleration and the Life Course (ALAC)” the team is now seeking a dedicated PhD Student.